Similarly, the levels of IL-2 were substantially higher in patients with HNSCC (14.9 ± 4.1 pg/mL) than in healthy controls (2.31 ± 1.1 pg/mL) (p < 0.0001). The gene discussed is IL2; the disease is head and neck squamous cell carcinoma.